Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Credit Suisse High Yield Bond Fund | DHY | Nov 25, 2024 | 2.22 | -0.45 |
Credo Technology | CRDO | Nov 25, 2024 | 47.07 | +2.68 |
Crescent Capital BDC | CCAP | Nov 25, 2024 | 19.18 | -0.21 |
Crescent Energy | CRGY | Nov 25, 2024 | 14.85 | -2.81 |
Cresud A ADR | CRESY | Nov 25, 2024 | 12.25 | +7.74 |
Crexendo | CXDO | Nov 25, 2024 | 5.22 | -0.38 |
CRH | CRH | Nov 25, 2024 | 102.80 | +1.38 |
Cricut A | CRCT | Nov 25, 2024 | 5.24 | +2.75 |
Crinetics Pharmaceuticals | CRNX | Nov 25, 2024 | 56.09 | +0.05 |
CRISPR Therapeutics | CRSP | Nov 25, 2024 | 50.40 | +5.26 |
Criteo ADR | CRTO | Nov 25, 2024 | 40.02 | +0.16 |
Critical Metals | CRML | Nov 25, 2024 | 6.47 | +4.35 |
Crocs | CROX | Nov 25, 2024 | 108.53 | +2.31 |
Cronos Group | CRON | Nov 25, 2024 | 2.13 | +2.40 |
Cross Country Healthcare | CCRN | Nov 25, 2024 | 10.87 | +5.13 |
Cross Timbers Royalty Royalty Trust | CRT | Nov 25, 2024 | 10.78 | -1.64 |
CrossAmerica Partners LP Unit | CAPL | Nov 25, 2024 | 20.43 | +0.54 |
CrossFirst Bankshares | CFB | Nov 25, 2024 | 17.95 | -0.06 |
CrowdStrike A | CRWD | Nov 25, 2024 | 363.68 | -2.30 |
Crown Castle | CCI | Nov 25, 2024 | 106.08 | +0.61 |
Crown Crafts | CRWS | Nov 25, 2024 | 4.57 | +1.11 |
Crown ElectroKinetics | CRKN | Nov 25, 2024 | 0.42 | -35.68 |
Crown Holdings | CCK | Nov 25, 2024 | 92.62 | -0.22 |
Crown LNG | CGBS | Nov 25, 2024 | 0.36 | +4.62 |
Cryo-Cell International | CCEL | Nov 25, 2024 | 8.87 | +6.23 |
CryoPort | CYRX | Nov 25, 2024 | 6.65 | +1.37 |
CS Disco | LAW | Nov 25, 2024 | 5.91 | +2.07 |
CSG Systems International | CSGS | Nov 25, 2024 | 55.22 | -0.53 |
CSP | CSPI | Nov 25, 2024 | 18.49 | +7.63 |
CSW Industrials | CSWI | Nov 25, 2024 | 432.01 | +1.25 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.